Delivery Order SPE2DB24D2011-SPE2DB24FBQJB

Award Date 7/1/24
Potential Completion Date 7/2/24
Potential Value $64K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This contract award to Amerisourcebergen Drug Corp's Corporate Office division is for the delivery of the pharmaceutical product Repatha (140 mg/mL) to the Defense Logistics Agency (DLA). The $3,419.01 firm fixed-price delivery order has a completion date of May 22, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a single-award Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support Medical through December 2025. This IDC serves as the...
This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office division provides for the delivery of Repatha 140 mg/ml SureClickML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,095.46 firm fixed price delivery order has a completion date of June 20, 2024 and was awarded on June 18, 2024. The contract does not have a set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, leverages its extensive supply chain to...
This federal contract award was issued by the Medical Supply Chain division of the U.S. Department of Defense to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,186.29 Delivery Order is for the supply of the prescription drug Repatha (140 mg/ml) and has a firm fixed price. The contract has an ultimate completion date of May 6, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with...
This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, provides for the delivery of Repatha, a 140 mg/ml SureClick injection, to the U.S. government. The $1,355.76 firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical and has a completion date of July 5, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to deliver a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,300.77 firm fixed-price delivery order is for the supply of Repatha 140 mg/ml SureClick medication. The contract has an ultimate completion date of May 7, 2025 and is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,195.86 firm-fixed-price delivery order covers the supply of the drug Repatha (140 mg/mL) and has an ultimate completion date of December 6, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $1,258.42 Firm Fixed Price Delivery Order is for the supply of the pharmaceutical product Repatha 140 mg/ml SureClick. Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division, a major pharmaceutical distributor. The $1,016.82 Delivery Order contract is a Firm Fixed Price arrangement to provide Repatha 140 mg/ml SureClick syringes to the DLA. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical as the primary vehicle to deliver a wide range of pharmaceutical products and...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the major pharmaceutical distributor Amerisourcebergen Corporation, is for the delivery of Repatha, a 140 mg/mL medication, to the Defense Logistics Agency (DLA). The $2,352.63 firm fixed-price delivery order has a completion date of May 29, 2024. Amerisourcebergen holds two Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical and the Department of Justice Federal Bureau of Investigation, valued up...
This federal contract award is to Amerisourcebergen Drug Corp, a for-profit subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The award, valued at $4,067.28, is a firm fixed price delivery order from the Defense Logistics Agency (DLA) to provide Repatha 140 mg/mL SureClick medication. The contract has a completion date of February 12, 2024 and was awarded on February 9, 2024. This award is part of a larger indefinite delivery...
  • SPE2DB24D2011
    Indefinite Delivery Contract
  • SPE2DB24D2011-SPE2DB24FBQJB
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the prescription drug Repatha (140 mg/mL) to the Defense Logistics Agency (DLA). The contract, valued at $63,918.91, is a Firm Fixed Price Delivery Order with a completion date of July 2, 2024. Amerisourcebergen, a major pharmaceutical distribution company, has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025, to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This contract is not designated as a set-aside.

Generated 10/1/24, 5:12 PM